Skip to main content

HomeLegalNAD+ in New York

Educational — Not Legal AdviceUpdated

NAD+ in New York: Legal Status & Provider Guide (2026)

Quick Answer

NAD+ is a prescription substance in the United States. NAD+ in injectable form can be lawfully compounded by 503A pharmacies under a valid prescription. Oral NAD+ precursors (NR, NMN) are available as dietary supplements without a prescription. Injectable NAD+ protocols require physician oversight and pharmacy compounding. In New York, compounding is governed by the New York State Board of Pharmacy (NYSBP). New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.

Federal Legal Status

FDA Approval Status

NAD+ is not FDA-approved as a prescription drug. It is generally recognized as a nutritional supplement precursor (via NR and NMN) when taken orally. Injectable NAD+ has been compounded by licensed pharmacies and is considered legally permissible under current FDA guidance in IV/injection form when prescribed.

Compounding Pharmacy Rules (Federal)

Injectable NAD+ (nicotinamide adenine dinucleotide) can be compounded by licensed 503A pharmacies under a valid prescription. It is not on the 503B bulk substances list but has historically been offered by many compounding pharmacies for IV infusion or subcutaneous injection under physician oversight. Its regulatory status is more permissive than most synthetic peptides.

Also Known As

Nicotinamide Adenine Dinucleotide · NAD · β-NAD+

Primary Research Areas

  • Cellular energy
  • Anti-aging
  • Neurological support
  • Addiction recovery support
  • Metabolic health

New York Pharmacy Board & Compounding Rules

Compounding Overview

New York has among the most stringent pharmacy and prescribing regulations in the country. The New York State Board of Pharmacy enforces USP 797 and 795 standards and requires all compounding pharmacies to meet detailed quality and documentation requirements. New York has been particularly active in enforcing against unapproved compounded medications. In-state telehealth peptide providers are subject to strict New York Medical Board oversight.

Notable Rules

  • New York requires compounding pharmacies to register separately for sterile compounding.
  • The New York Department of Health has enforcement authority over unlicensed pharmaceutical activity.
  • New York has stricter-than-federal requirements for documentation of medical necessity for compounded preparations.
  • Interstate prescribing into New York requires a New York state license.
  • New York and Pennsylvania maintain reciprocal pharmacy licensure recognition for some categories.

Prescribing Requirements in New York

New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.

About NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells, central to energy metabolism and DNA repair. Research interest has expanded significantly with studies linking NAD+ decline to aging. Clinical research focuses on replenishment via IV infusion or oral precursors.

For more research information, mechanism of action, and provider availability, see the NAD+ research profile on PeptideBase.

Frequently Asked Questions

Is injectable NAD+ legal?
Injectable NAD+ can be legally compounded by licensed 503A compounding pharmacies under a valid physician prescription. It is not FDA-approved as a drug but has a permissive compounding status compared to many synthetic peptides.
What is the difference between oral NAD+ supplements and IV NAD+?
Oral supplements typically deliver NAD+ precursors (NR or NMN) which the body converts. IV NAD+ delivers the coenzyme directly into the bloodstream, which proponents claim produces faster and more pronounced effects, though comparative clinical data is limited.

NAD+ Providers in New York

No providers currently listed in New York for NAD+. Browse the full directory to find providers offering NAD+.

Browse all NAD+ providers →

NAD+ Legal Status in Other States

Pharmacy board rules and compounding regulations vary by state. Compare NAD+ legal status across other major markets:

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.